BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31231367)

  • 1. LPA
    Mathew D; Kremer KN; Strauch P; Tigyi G; Pelanda R; Torres RM
    Front Immunol; 2019; 10():1159. PubMed ID: 31231367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
    Oda SK; Strauch P; Fujiwara Y; Al-Shami A; Oravecz T; Tigyi G; Pelanda R; Torres RM
    Cancer Immunol Res; 2013 Oct; 1(4):245-55. PubMed ID: 24455753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of CD8 T-cell signaling, metabolism, and cytotoxic activity by extracellular lysophosphatidic acid.
    Torres RM; Turner JA; D'Antonio M; Pelanda R; Kremer KN
    Immunol Rev; 2023 Aug; 317(1):203-222. PubMed ID: 37096808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C delta localizes to secretory lysosomes in CD8+ CTL and directly mediates TCR signals leading to granule exocytosis-mediated cytotoxicity.
    Ma JS; Haydar TF; Radoja S
    J Immunol; 2008 Oct; 181(7):4716-22. PubMed ID: 18802074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct T cell receptor signaling requirements for perforin- or FasL-mediated cytotoxicity.
    Esser MT; Krishnamurthy B; Braciale VL
    J Exp Med; 1996 Apr; 183(4):1697-706. PubMed ID: 8666927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis.
    Lee SC; Fujiwara Y; Liu J; Yue J; Shimizu Y; Norman DD; Wang Y; Tsukahara R; Szabo E; Patil R; Banerjee S; Miller DD; Balazs L; Ghosh MC; Waters CM; Oravecz T; Tigyi GJ
    Mol Cancer Res; 2015 Jan; 13(1):174-85. PubMed ID: 25158955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic Acid Is an Inflammatory Lipid Exploited by Cancers for Immune Evasion
    Mathew D; Torres RM
    Front Immunol; 2020; 11():531910. PubMed ID: 33584637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8
    Matas-Rico E; Frijlink E; van der Haar Àvila I; Menegakis A; van Zon M; Morris AJ; Koster J; Salgado-Polo F; de Kivit S; Lança T; Mazzocca A; Johnson Z; Haanen J; Schumacher TN; Perrakis A; Verbrugge I; van den Berg JH; Borst J; Moolenaar WH
    Cell Rep; 2021 Nov; 37(7):110013. PubMed ID: 34788605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells.
    Shen DT; Ma JS; Mather J; Vukmanovic S; Radoja S
    J Leukoc Biol; 2006 Oct; 80(4):827-37. PubMed ID: 16891618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response.
    Hu J; Oda SK; Shotts K; Donovan EE; Strauch P; Pujanauski LM; Victorino F; Al-Shami A; Fujiwara Y; Tigyi G; Oravecz T; Pelanda R; Torres RM
    J Immunol; 2014 Jul; 193(1):85-95. PubMed ID: 24890721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autotaxin produced by stromal cells promotes LFA-1-independent and Rho-dependent interstitial T cell motility in the lymph node paracortex.
    Katakai T; Kondo N; Ueda Y; Kinashi T
    J Immunol; 2014 Jul; 193(2):617-26. PubMed ID: 24935929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific clonal expansion and cytolytic effector function of CD8+ T lymphocytes depend on the transcription factor Bcl11b.
    Zhang S; Rozell M; Verma RK; Albu DI; Califano D; VanValkenburgh J; Merchant A; Rangel-Moreno J; Randall TD; Jenkins NA; Copeland NG; Liu P; Avram D
    J Exp Med; 2010 Aug; 207(8):1687-99. PubMed ID: 20660613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autotaxin determines colitis severity in mice and is secreted by B cells in the colon.
    Lin S; Haque A; Raeman R; Guo L; He P; Denning TL; El-Rayes B; Moolenaar WH; Yun CC
    FASEB J; 2019 Mar; 33(3):3623-3635. PubMed ID: 30481488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis.
    Radoja S; Saio M; Schaer D; Koneru M; Vukmanovic S; Frey AB
    J Immunol; 2001 Nov; 167(9):5042-51. PubMed ID: 11673513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
    Shier P; Ngo K; Fung-Leung WP
    J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of LAT in the granule-mediated cytotoxicity of CD8 T cells.
    Ou-Yang CW; Zhu M; Fuller DM; Sullivan SA; Chuck MI; Ogden S; Li QJ; Zhang W
    Mol Cell Biol; 2012 Jul; 32(14):2674-84. PubMed ID: 22566687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCR down-regulation boosts T-cell-mediated cytotoxicity and protection against poxvirus infections.
    Hansen AK; Regner M; Bonefeld CM; Boding L; Kongsbak M; Ødum N; Müllbacher A; Geisler C; von Essen MR
    Eur J Immunol; 2011 Jul; 41(7):1948-57. PubMed ID: 21590764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na
    Jenkin KA; He P; Yun CC
    Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G433-G442. PubMed ID: 29792531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPA suppresses T cell function by altering the cytoskeleton and disrupting immune synapse formation.
    Kremer KN; Buser A; Thumkeo D; Narumiya S; Jacobelli J; Pelanda R; Torres RM
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2118816119. PubMed ID: 35394866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid and autotaxin: emerging roles in innate and adaptive immunity.
    Georas SN
    Immunol Res; 2009 Dec; 45(2-3):229-38. PubMed ID: 19184538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.